Entera Bio (ENTX) News Today $2.50 +0.15 (+6.34%) As of 10:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Entera Bio announces highlights from presentation at WCO-IFO-ESCEO on EB613April 15, 2025 | markets.businessinsider.comShort Interest in Entera Bio Ltd. (NASDAQ:ENTX) Declines By 13.7%Entera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 86,100 shares, a drop of 13.7% from the February 28th total of 99,800 shares. Approximately 0.3% of the company's shares are short sold. Based on an average daily volume of 114,700 shares, the days-to-cover ratio is presently 0.8 days.April 4, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Issues Earnings ResultsEntera Bio (NASDAQ:ENTX - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.02.March 29, 2025 | marketbeat.comEntera Bio Reports Transformative Year in 2024March 29, 2025 | tipranks.comEntera Bio Announces Full Year 2024 Financial Results and Provides Business UpdatesMarch 28, 2025 | globenewswire.comEntera Bio Ltd.March 26, 2025 | wsj.comEntera Bio's (ENTX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $10.00 target price on shares of Entera Bio in a research note on Tuesday.March 19, 2025 | marketbeat.comOpko Health, Entera Bio to Collaborate on Tablet for Obesity, Metabolic and Fibrotic DisordersMarch 17, 2025 | marketwatch.comOpko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptideMarch 17, 2025 | markets.businessinsider.comOpko Health, Entera Bio enter into collaboration agreementMarch 17, 2025 | markets.businessinsider.comEntera Bio Collaborates with OPKO for Oral GLP-1/GlucagonMarch 17, 2025 | tipranks.comOPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic DisordersMarch 17, 2025 | globenewswire.comEntera Bio (ENTX) Expected to Announce Quarterly Earnings on FridayEntera Bio (NASDAQ:ENTX) will be releasing earnings before the market opens on Friday, March 14, Financial Modeling Prep reports.March 7, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest UpdateEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 104,500 shares, a growth of 59.5% from the January 31st total of 65,500 shares. Based on an average trading volume of 114,000 shares, the short-interest ratio is currently 0.9 days.March 2, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Down 1.4% - Time to Sell?Entera Bio (NASDAQ:ENTX) Stock Price Down 1.4% - Should You Sell?February 26, 2025 | marketbeat.comEntera Bio to Participate in Upcoming EventsFebruary 24, 2025 | globenewswire.comEntera Bio announces acceptance of EB613 abstracts for WCO-IOF-ESCEOFebruary 19, 2025 | markets.businessinsider.comShort Interest in Entera Bio Ltd. (NASDAQ:ENTX) Declines By 31.6%Entera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 65,500 shares, a decrease of 31.6% from the January 15th total of 95,800 shares. Based on an average daily volume of 145,000 shares, the short-interest ratio is presently 0.5 days.February 15, 2025 | marketbeat.comIs Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?February 6, 2025 | uk.finance.yahoo.comPerigon Wealth Management LLC Takes $325,000 Position in Entera Bio Ltd. (NASDAQ:ENTX)Perigon Wealth Management LLC purchased a new stake in Entera Bio Ltd. (NASDAQ:ENTX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 145,843 shares of the company's stock, valued at approximately $325,0February 3, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Significant Growth in Short InterestEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 95,800 shares, a growth of 102.5% from the December 31st total of 47,300 shares. Based on an average daily trading volume, of 132,000 shares, the short-interest ratio is currently 0.7 days.January 31, 2025 | marketbeat.comEntera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceJanuary 27, 2025 | globenewswire.comEntera Bio (NASDAQ:ENTX) Stock Price Up 1.1% - Still a Buy?Entera Bio (NASDAQ:ENTX) Trading Up 1.1% - Should You Buy?January 7, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short InterestEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 52,600 shares, a growth of 19.0% from the October 31st total of 44,200 shares. Based on an average daily volume of 64,200 shares, the days-to-cover ratio is presently 0.8 days.December 1, 2024 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Large Increase in Short InterestEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 44,200 shares, an increase of 9.4% from the October 15th total of 40,400 shares. Based on an average trading volume of 31,500 shares, the days-to-cover ratio is currently 1.4 days.November 17, 2024 | marketbeat.comHC Wainwright Decreases Earnings Estimates for Entera BioEntera Bio Ltd. (NASDAQ:ENTX - Free Report) - HC Wainwright dropped their FY2024 earnings per share estimates for Entera Bio in a research report issued to clients and investors on Monday, November 11th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0November 14, 2024 | marketbeat.comEntera Bio Buy Rating: Strong Financials, Strategic Developments, and Promising Pipeline Drive Analyst ConfidenceNovember 12, 2024 | markets.businessinsider.comEntera Bio's (ENTX) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $10.00 target price on shares of Entera Bio in a report on Monday.November 11, 2024 | marketbeat.comEntera Bio Highlights Q3 2024 Financials and FDA AnticipationNovember 9, 2024 | markets.businessinsider.comEntera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNovember 8, 2024 | globenewswire.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 14.4% in OctoberEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 40,400 shares, a drop of 14.4% from the September 30th total of 47,200 shares. Based on an average daily volume of 37,300 shares, the days-to-cover ratio is currently 1.1 days.October 29, 2024 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in SeptemberEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 47,200 shares, an increase of 38.4% from the September 15th total of 34,100 shares. Based on an average trading volume of 41,000 shares, the short-interest ratio is presently 1.2 days.October 13, 2024 | marketbeat.comBuy Rating Affirmed for Entera Bio’s EB613: A Game Changer in Osteoporosis TreatmentOctober 8, 2024 | markets.businessinsider.comEntera Bio (NASDAQ:ENTX) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $10.00 price target on shares of Entera Bio in a research report on Monday.October 7, 2024 | marketbeat.comEntera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersSeptember 25, 2024 | globenewswire.comQuantum Genomics Société Anonyme (2QG.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comWe're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn RateAugust 30, 2024 | finance.yahoo.comEntera Bio to Participate in Upcoming Investor and Scientific ConferencesAugust 20, 2024 | globenewswire.comEntera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX)Entera Bio Ltd. (NASDAQ:ENTX - Free Report) - Investment analysts at HC Wainwright lifted their Q3 2024 earnings per share estimates for shares of Entera Bio in a report issued on Monday, August 12th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.05)August 15, 2024 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in JulyEntera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 24,900 shares, a decrease of 51.0% from the July 15th total of 50,800 shares. Based on an average daily trading volume, of 78,300 shares, the short-interest ratio is currently 0.3 days.August 13, 2024 | marketbeat.comEntera Bio Receives Strong Buy Rating Amid Anticipated FDA Ruling and Pipeline ProgressAugust 12, 2024 | markets.businessinsider.comEntera Bio (NASDAQ:ENTX) Releases Earnings ResultsEntera Bio (NASDAQ:ENTX - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). The business had revenue of $0.06 million during the quarter.August 12, 2024 | marketbeat.comEntera Bio Ltd.: Entera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesAugust 11, 2024 | finanznachrichten.deEntera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesAugust 9, 2024 | globenewswire.comEntera Bio (NASDAQ:ENTX) Stock Price Up 1.9%Entera Bio (NASDAQ:ENTX) Trading 1.9% HigherAugust 1, 2024 | marketbeat.com3 Meme Stocks That Can Surge by 200% Before 2025July 8, 2024 | investorplace.com3 Clinical-Stage Biotech Stocks to Buy for Multibagger ReturnsJuly 2, 2024 | investorplace.com3 Meme Stocks to Buy on the Dip: June 2024June 25, 2024 | investorplace.com7 Penny Stocks to Turn $3 Into $1 Million Within 36 MonthsJune 20, 2024 | investorplace.comRag to Riches: 3 Penny Stocks That Could Make Early Investors RichJune 20, 2024 | investorplace.com Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Email Address ENTX Media Mentions By Week ENTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENTX News Sentiment▼0.000.74▲Average Medical News Sentiment ENTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENTX Articles This Week▼01▲ENTX Articles Average Week Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies REGENXBIO News Today Olema Pharmaceuticals News Today Benitec Biopharma News Today COMPASS Pathways News Today Alpha Teknova News Today Allogene Therapeutics News Today Entrada Therapeutics News Today Arcturus Therapeutics News Today Taysha Gene Therapies News Today Heron Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENTX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENTX Stock Free ENTX Stock Alerts